Predictors of Long-Term Disease Control and Survival for HER2-Positive Advanced Breast Cancer Patients Treated With Pertuzumab, Trastuzumab, and Docetaxel

Background: HER2-positive advanced breast cancer (ABC) is associated with significant heterogeneity in long-term disease control and survival. Prognostic models for HER2-positive ABC patients considering first-line pertuzumab, trastuzumab, and docetaxel have not been evaluated. Methods: A pre-treatm...

全面介紹

Na minha lista:
書目詳細資料
發表在:Front Oncol
Main Authors: Hopkins, Ashley M., Rowland, Andrew, McKinnon, Ross A., Sorich, Michael J.
格式: Artigo
語言:Inglês
出版: Frontiers Media S.A. 2019
主題:
Oncology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6713878/
https://ncbi.nlm.nih.gov/pubmed/31508358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00789
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍